Judah Frommer
Stock Analyst at Morgan Stanley
(3.71)
# 2,110
Out of 4,690 analysts
490
Total ratings
51.9%
Success rate
4.1%
Average return
Main Sectors:
Stocks Rated by Judah Frommer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGMB AgomAb Therapeutics NV | Maintained: Buy | $28 | $12.82 | +118.41% | 9 | Aug 31, 2026 | |
| LKFT Lakefront Biotherapeutics NV | Reiterated: Hold | $26 | $29.04 | -10.47% | 56 | Aug 31, 2026 | |
| RGNX REGENXBIO | Maintained: Buy | $18 | $8.06 | +123.46% | 22 | Aug 25, 2026 | |
| QTTB Q32 Bio | Initiated Coverage: Buy | $34 | $16.36 | +107.82% | 1 | Aug 24, 2026 | |
| FDMT 4D Molecular Therapeutics | Rated: Hold | n/a | $15.39 | - | 14 | Aug 17, 2026 | |
| BLTE Belite Bio | Maintained: Buy | $201 → $206 | $158.87 | +29.67% | 3 | Aug 17, 2026 | |
| ZBIO Zenas BioPharma | Maintained: Hold | $22 → $32 | $31.65 | +1.11% | 12 | Aug 17, 2026 | |
| AVLN Avalyn Pharma | Rated: Buy | $53 → $57 | $37.69 | +51.23% | 3 | Aug 13, 2026 | |
| KLRS Kalaris Therapeutics | Rated: Buy | $14 | $4.10 | +241.46% | 4 | Aug 12, 2026 | |
| ENGN enGene Therapeutics | Maintained: Sell | n/a | $1.81 | - | 10 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $23.58 | +56.91% | 19 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 | $1.61 | +86.34% | 15 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 → $19 | $13.61 | +39.60% | 2 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 → $23 | $18.08 | +27.21% | 7 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $26 | $13.67 | +90.20% | 9 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $40 → $46 | $40.57 | +13.38% | 11 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $35 | $33.02 | +6.00% | 5 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $34 → $38 | $24.78 | +53.35% | 7 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $119 → $135 | $121.05 | +11.52% | 12 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $18 | $14.20 | +26.76% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $93 → $104 | $71.06 | +46.36% | 27 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $104 → $119 | $127.98 | -7.02% | 14 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $132 → $180 | $116.15 | +54.97% | 7 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $141 → $139 | $18.13 | n/a | 17 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $138 | $0.0003 | n/a | 9 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $5.62 | n/a | 8 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $0.7224 | n/a | 8 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $7.38 | n/a | 4 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $32.32 | n/a | 7 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $22 | $26.85 | n/a | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $7 | $12.86 | n/a | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $13 | $3.08 | n/a | 4 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $11 → $8 | $3.84 | n/a | 9 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $55 | $47.46 | n/a | 6 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $46 | $123.98 | n/a | 3 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $3.5 | $33.48 | n/a | 1 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $24 | $109.37 | n/a | 7 | Aug 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22 → $26 | $86.13 | n/a | 10 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $12.61 | n/a | 2 | Jul 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $90 → $95 | $76.35 | n/a | 10 | Jul 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $328 | $971.40 | n/a | 6 | Jul 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $35 | $59.08 | n/a | 28 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $125 → $116 | $262.72 | n/a | 9 | Jun 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €22.00 → €24.00 | €31.38 | n/a | 3 | Jun 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $98 → $107 | $136.75 | n/a | 19 | May 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $154 → $178 | $125.33 | n/a | 10 | May 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $31 → $38 | $98.49 | n/a | 4 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $67 → $63 | $83.86 | n/a | 17 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39 | $105.78 | n/a | 7 | May 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $17.22 | n/a | 1 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $36.52 | n/a | 1 | Mar 6, 2019 |
AgomAb Therapeutics NV
Aug 31, 2026
Maintained: Buy
Price Target: $28
Current: $12.82
Upside: +118.41%
Lakefront Biotherapeutics NV
Aug 31, 2026
Reiterated: Hold
Price Target: $26
Current: $29.04
Upside: -10.47%
REGENXBIO
Aug 25, 2026
Maintained: Buy
Price Target: $18
Current: $8.06
Upside: +123.46%
Q32 Bio
Aug 24, 2026
Initiated Coverage: Buy
Price Target: $34
Current: $16.36
Upside: +107.82%
4D Molecular Therapeutics
Aug 17, 2026
Rated: Hold
Price Target: n/a
Current: $15.39
Upside: -
Belite Bio
Aug 17, 2026
Maintained: Buy
Price Target: $201 → $206
Current: $158.87
Upside: +29.67%
Zenas BioPharma
Aug 17, 2026
Maintained: Hold
Price Target: $22 → $32
Current: $31.65
Upside: +1.11%
Avalyn Pharma
Aug 13, 2026
Rated: Buy
Price Target: $53 → $57
Current: $37.69
Upside: +51.23%
Kalaris Therapeutics
Aug 12, 2026
Rated: Buy
Price Target: $14
Current: $4.10
Upside: +241.46%
enGene Therapeutics
Aug 12, 2026
Maintained: Sell
Price Target: n/a
Current: $1.81
Upside: -
Aug 12, 2026
Maintained: Buy
Price Target: $37
Current: $23.58
Upside: +56.91%
Aug 11, 2026
Maintained: Hold
Price Target: $3
Current: $1.61
Upside: +86.34%
Aug 11, 2026
Rated: Buy
Price Target: $20 → $19
Current: $13.61
Upside: +39.60%
Aug 10, 2026
Rated: Buy
Price Target: $20 → $23
Current: $18.08
Upside: +27.21%
Aug 10, 2026
Rated: Buy
Price Target: $26
Current: $13.67
Upside: +90.20%
Aug 7, 2026
Rated: Buy
Price Target: $40 → $46
Current: $40.57
Upside: +13.38%
Aug 7, 2026
Maintained: Hold
Price Target: $35
Current: $33.02
Upside: +6.00%
Aug 6, 2026
Rated: Buy
Price Target: $34 → $38
Current: $24.78
Upside: +53.35%
Aug 6, 2026
Rated: Buy
Price Target: $119 → $135
Current: $121.05
Upside: +11.52%
Aug 6, 2026
Maintained: Buy
Price Target: $17 → $18
Current: $14.20
Upside: +26.76%
Jul 31, 2026
Maintained: Buy
Price Target: $93 → $104
Current: $71.06
Upside: +46.36%
Jul 29, 2026
Maintained: Hold
Price Target: $104 → $119
Current: $127.98
Upside: -7.02%
Jul 24, 2026
Rated: Buy
Price Target: $132 → $180
Current: $116.15
Upside: +54.97%
Aug 3, 2023
Maintained: Hold
Price Target: $141 → $139
Current: $18.13
Upside: n/a
Jun 5, 2023
Maintained: Buy
Price Target: $138
Current: $0.0003
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $13
Current: $5.62
Upside: n/a
May 15, 2023
Reiterated: Buy
Price Target: $40
Current: $0.7224
Upside: n/a
May 12, 2023
Reiterated: Buy
Price Target: $9
Current: $7.38
Upside: n/a
May 5, 2023
Reiterated: Buy
Price Target: $28
Current: $32.32
Upside: n/a
Apr 3, 2023
Maintained: Buy
Price Target: $21 → $22
Current: $26.85
Upside: n/a
Mar 31, 2023
Maintained: Buy
Price Target: $8 → $7
Current: $12.86
Upside: n/a
Mar 28, 2023
Maintained: Buy
Price Target: $16 → $13
Current: $3.08
Upside: n/a
Mar 9, 2023
Downgraded: Hold
Price Target: $11 → $8
Current: $3.84
Upside: n/a
Feb 28, 2023
Maintained: Buy
Price Target: $51 → $55
Current: $47.46
Upside: n/a
Feb 24, 2023
Reiterated: Buy
Price Target: $57 → $46
Current: $123.98
Upside: n/a
May 11, 2022
Maintained: Sell
Price Target: $3.5
Current: $33.48
Upside: n/a
Aug 4, 2020
Maintained: Buy
Price Target: $23 → $24
Current: $109.37
Upside: n/a
Jul 30, 2020
Maintained: Hold
Price Target: $22 → $26
Current: $86.13
Upside: n/a
Jul 27, 2020
Maintained: Buy
Price Target: $18
Current: $12.61
Upside: n/a
Jul 22, 2020
Rated: Hold
Price Target: $90 → $95
Current: $76.35
Upside: n/a
Jul 8, 2020
Maintained: Hold
Price Target: $328
Current: $971.40
Upside: n/a
Jun 18, 2020
Maintained: Hold
Price Target: $35
Current: $59.08
Upside: n/a
Jun 10, 2020
Rated: Buy
Price Target: $125 → $116
Current: $262.72
Upside: n/a
Jun 3, 2020
Maintained: Hold
Price Target: €22.00 → €24.00
Current: €31.38
Upside: n/a
May 28, 2020
Rated: Buy
Price Target: $98 → $107
Current: $136.75
Upside: n/a
May 22, 2020
Maintained: Hold
Price Target: $154 → $178
Current: $125.33
Upside: n/a
May 21, 2020
Rated: Buy
Price Target: $31 → $38
Current: $98.49
Upside: n/a
May 5, 2020
Rated: Buy
Price Target: $67 → $63
Current: $83.86
Upside: n/a
May 4, 2020
Maintained: Buy
Price Target: $39
Current: $105.78
Upside: n/a
Mar 6, 2020
Downgraded: Hold
Price Target: n/a
Current: $17.22
Upside: n/a
Mar 6, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $36.52
Upside: n/a